Skip to main content

Eli Lilly announced results of Jaypirca (pirtobrutinib)

Eli Lilly and Company announced positive topline results from the Phase 3 BRUIN CLL-322 trial of Jaypirca (pirtobrutinib), a non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, plus venetoclax and rituximab versus venetoclax and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL). Treatment in both study arms was administered for up to two years, after which patients do not take any CLL therapy until their disease progresses. 

Johnson & Johnson Highlights Favorable 12-Month Interim Results for the VARIPULSE Platform at EHRA 2026

Johnson & Johnson today announced favorable 12-month interim effectiveness and safety results from VARIPURE, the largest prospective post-market follow-up study evaluating first-time pulsed field ablation (PFA) using the VARIPULSE Platform. The data were presented at the PFA Summit during the 2026 European Heart Rhythm Association (EHRA) Annual Meeting in Paris and simultaneously published in Europace.

Staff Selection Commission hiring Pharmacists | 136 posts for DGHS and Department of Health and Family Welfare
12th class pass from a recognised Board; Diploma in pharmacy from a recognised Institute with registration with respective State pharmacy Council; or B Pharma Degree. Staff Selection Commission for DGHS and Department of Health and Family Welfare
ICMR funded project positions for Pharma and Life Science candidates at TMC
Graduation in Life Science / B.Pharm with Post graduate Diploma in Clinical research & Three years’ experience is Mandatory Or Post graduate Degree in Life Science / M.Pharm with Post graduate Diploma in Clinical research is Mandatory & Experience is Desirable
Recruitment for Pharmacists (10 posts) under Office of the CMHO
Degree or Diploma course in Pharmacy, along with valid registration with the Paramedical Council
Fellowships for Pharmacy / Life Sciences / Biotechnology at NIPER
M.Pharma /M.S. Pharma /MSc or Equivalent with specialization in Pharmaceutics/ Pharmaceutical Biotechnology or equivalent with specialization in Pharmacy/ Life Sciences/ Biotechnology with hands on experience in cell culture and animal studies for skin diseases.
MPMMCC Offers Research Opportunities for Pharma, Science, PG in Clinical Research Candidates
MSc / M.Pharm (PG Diploma in Clinical Research is mandatory)/ M.Sc. in Clinical Research/ MBBS/ BDS/ BAMS/ BHMS/ BUMS (PG Diploma in Clinical Research is Mandatory) or PharmD or Equivalent Qualification
BRIC-NIPGR Short Term Research Fellowship for Pharma candidates
Doctoral Degree in Science/Engineering/Technology/Pharma/MD/MS from a recognized University or equivalent.
Research positions at Regional Centre for Biotechnology
M.Sc. or any other equivalent course in Biotechnology with at least 60% marks. Experience in handling fungal culture is highly desirable.
Admission to the Ph.D. program in the Department of Biotechnology, IITH
Applications are invited from suitably qualified & motivated candidates for admission to the Ph.D. program in the Department of Biotechnology, IITH